Spark Investment Management’s Utah Medical Products UTMD Stock Holding History

Spark Investment Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,000	Closed	-$471K	–	812
2018 Q3	$471K	Hold	5,000	–	–	0.03%	470
2018 Q2	$550K	Buy	+5,000	New	+$522K	0.03%	433
2018 Q1	–	Sell	-3,000	Closed	-$244K	–	732
2017 Q4	$244K	Sell	3,000 -1,500	-33%	-$117K	0.01%	543
2017 Q3	$330K	Hold	4,500	–	–	0.02%	543
2017 Q2	$325K	Buy	+4,500	New	+$296K	0.02%	568
2016 Q4	–	Sell	-3,900	Closed	-$233K	–	882
2016 Q3	$233K	Hold	3,900	–	–	0.02%	641
2016 Q2	$245K	Buy	+3,900	New	+$252K	0.02%	585

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Spark Investment Management's UTMD Position: Q4 2018 in Review

Spark Investment Management sold out of Utah Medical Products (UTMD) in Q4 2018, closing a stake of 5,000 shares — an estimated $471K sold.

Spark Investment Management first reported a position in UTMD in Q2 2016 and held it in 7 quarters. The position peaked at $550K in Q2 2018. 88 funds tracked by Wall St. Rank hold UTMD as of Q4 2018.

Spark Investment Management reported no remaining Utah Medical Products position as of Q4 2018 after selling out during the quarter.
Spark Investment Management sold 5,000 Utah Medical Products shares in Q4 2018, an estimated $471K.
Spark Investment Management first reported a position in Utah Medical Products in Q2 2016 and held it in 7 quarters.
Spark Investment Management's Utah Medical Products position peaked at $550K in Q2 2018.
88 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.